Giant Biogene Holding Co Ltd (HKSE:02367) Share Price

Company Profile

Business description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Contact
No. 1855, Shanglin Yuan 7th Road
Chang’an District
Shaanxi Province
Xi’an
CHN
https://www.xajuzi.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2026
Employees
2,162

Recommended

Investors will get to see if the new strategy and capital management framework are working.

Brian Han | 27 January 2026

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Sarah Hansen | 26 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,250.60	50.70	-0.55%
CAC 40	8,059.17	93.65	-1.15%
DAX 40	24,773.29	121.15	-0.49%
Dow JONES (US)	49,003.41	408.99	-0.83%
FTSE 100	10,164.86	42.94	-0.42%
HKSE	27,826.91	699.96	2.58%
NASDAQ	23,817.10	215.74	0.91%
Nikkei 225	53,358.71	25.17	0.05%
NZX 50 Index	13,412.87	98.01	-0.73%
S&P 500	6,978.60	0.00	0.00%
S&P/ASX 200	8,933.90	40.40	-0.45%
SSE Composite Index	4,151.24	11.33	0.27%